CNS THERAPEUTICS (OLD)
CNS Therapeutics is a private company based in St. Paul, Minn. CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain. In addition to its first FDA-approved product, Gablofen, CNS Therapeutics is currently collaborating with U.S. and international scientific experts to develop and test new treatments for pain and Parkinson's disease.
CNS THERAPEUTICS (OLD)
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2007-07-01
Address:
Saint Paul, Minnesota, United States
Country:
United States
Website Url:
http://www.cnstherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
800.778.7898
Total Funding:
10.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Pratik Shah Director & Founder @ CNS Therapeutics (Old)
Director & Founder
Founder
Official Site Inspections
http://www.cnstherapeutics.com
- Host name: www.impactofmma.com
- IP address: 146.214.96.145
- Location: St Louis United States
- Latitude: 38.6249
- Longitude: -90.4496
- Metro Code: 609
- Timezone: America/Chicago
- Postal: 63131
More informations about "CNS Therapeutics (Old)"
CNS Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CNS Therapeutics, Inc. of Hazelwood, MO. Get the latest business insights from Dun & Bradstreet.See details»
CNS Therapeutics Inc - Company Profile and News
Company profile page for CNS Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Bienvenue chez CXS Therapeutics
Plateforme de medtech spécialisée dans l'identification et le redéveloppement de molécules thérapeutiques dans le cadre de maladies du SNC.See details»
CNS Therapeutics (Old) - Crunchbase Company Profile & Funding
CNS Therapeutics is a private company based in St. Paul, Minn. CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous …See details»
CNS Therapeutics Overview | SignalHire Company Profile
Organization Website: cnstherapeutics.com : Phone Number +1 6512076959: CNS Therapeutics industries Pharma: Headquarters Location: 332 MINNESOTA ST, Saint Paul, Minnesota, …See details»
CNS Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 332 Minnesota Street Suite W1750. Saint Paul, Minnesota, 55101, United States. 651-207-6959See details»
CNS Pharmaceutical - Crunchbase Company Profile & Funding
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. CNS may also pursue the development of …See details»
Investor Relations - CNS Pharmaceuticals
CNS Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CNS Pharmaceuticals, Inc.'s performance made by these …See details»
CNS Therapy AG - VentureRadar
CNS Therapy AG VentureRadar profile. Find out more about CNS Therapy AG, Medical Device, Mental and Behavioral Health, Therapeutics, Brain Health and Cure Disease and .See details»
CNS Pharmaceuticals | Home
CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments for brain tumors.See details»
CNS Pharmaceuticals - Overview, News & Similar companies
Jan 29, 2024 CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering - PharmiWeb.com HOUSTON, TX / ACCESSWIRE / January 29, 2024 / CNS Pharmaceuticals, …See details»
Who We Are - CNS Pharmaceuticals
Mr. Downs is the Chief Financial Officer of CNS Pharmaceuticals, Inc. Mr. Downs has served in senior finance executive and public company director positions for over 20 years, primarily in …See details»
CNS Pharmaceuticals, Inc. (CNSP) Company Profile & Overview
Nov 8, 2019 2100 West Loop South, Suite 900 Houston, Texas 77027 United StatesSee details»
CNS Pharmaceuticals - Craft
Sep 18, 2024 CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors. It develops Berubicin, a drug for the …See details»
13 Central Nervous System Companies Worldwide - Biotech Careers
View the list and locations of 13 biotechnology companies engaged in Central Nervous System work.See details»
Worldwide CNS Therapeutics Industry to 2025 - Awareness …
Apr 14, 2021 Increased use of contract research organization services; and predictive planning to prevent late stage drug failure are few of the strategies adopted to infuse vigor in the CNS …See details»
Global CNS Therapeutics Industry (2020 to 2025) - Business Wire
Apr 12, 2021 Contacts. ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN …See details»
CNS THERAPEUTICS INC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CNS THERAPEUTICS INC of Saint Paul, MN. Get the latest business insights from Dun & Bradstreet.See details»
Market Size By Disease - Straits Research
Feb 23, 2024 Market Overview. The global CNS therapeutics market size was valued at USD 120.60 billion in 2022.It is estimated to reach USD 214.36 billion by 2031, growing at a CAGR …See details»
Pipeline - CNS Pharmaceuticals
Pipeline Future research targets Clinical Trials Information on our clinical trials Berubicin The first anthracycline to cross the blood brain barrier TPI 287 Late stage, novel, blood brain barrier …See details»